United Kingdom Seeks to Eliminate the Use of Metal-on-Metal Implants Due to High Failure Rate

Because of the high failure rates of metal on metal hip devices, and the potential for toxic exposure, the United Kingdom is moving to ban all metal-on-metal hip replacements performed at National Health Service [NHS] hospitals.  NHS is the publicly funded health care system in the U.K, the NHS seeks to stop these surgeries with [...]

November 1st, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation|Comments Off on United Kingdom Seeks to Eliminate the Use of Metal-on-Metal Implants Due to High Failure Rate

J&J’s DePuy Unit Abandons Pinnacle and All Metal Hip Implants

On May 16, 2013, in what many health advocates feel is a long overdue move, J&J’s DePuy Orthopedic unit announced it was stopping the manufacture of all metal replacement hips.  In August 2010 the unit recalled the DePuy ASR in the face of mounting evidence of high failure rates but continued to sell the all [...]

May 17th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation|Comments Off on J&J’s DePuy Unit Abandons Pinnacle and All Metal Hip Implants

Risperdal adds to DePuy and Ethicon Troubles for J&J

Johnson and Johnson (J&J), already embroiled in massive litigation in DePuy ASR artificial hips, and in the trans vaginal mesh litigation from its Ethicon Gynecare products, faces another significant issue over its mounting legal troubles stemming from its antipsychotic drug Risperdal.  The drug was approved in 1993 for use in adults and was also later [...]

May 12th, 2013|DePuy Hip Replacement, Drug and Medical Device Litigation, Transvaginal Mesh|Comments Off on Risperdal adds to DePuy and Ethicon Troubles for J&J